Neuroone Medical Technologies Corp (NMTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,353 | -1,960 | 0 | -13,074 | -5,983 |
| Depreciation Amortization | 38 | 19 | 0 | 34 | 21 |
| Accounts receivable | N/A | -72 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -444 | -243 | N/A | -241 | -34 |
| Other Working Capital | -569 | -224 | 0 | -460 | -428 |
| Other Operating Activity | 1,044 | 575 | 0 | 10,043 | 3,949 |
| Operating Cash Flow | $-4,284 | $-1,904 | $0 | $-3,698 | $-2,475 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2 | N/A | 0 | -66 | -40 |
| Investing Cash Flow | $-2 | $0 | $0 | $-66 | $-40 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | -3 | N/A | 8,358 | 3,235 |
| Common Stock Issued | 11,527 | 5,000 | N/A | -63 | 184 |
| Other Financing Activity | -3 | 0 | 0 | -968 | -417 |
| Financing Cash Flow | $11,524 | $4,997 | $0 | $7,327 | $3,002 |
| Beginning Cash Position | 4,036 | 4,036 | 0 | 261 | 261 |
| End Cash Position | 11,274 | 7,129 | 0 | 3,824 | 747 |
| Net Cash Flow | $7,238 | $3,093 | $0 | $3,563 | $487 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,284 | -1,904 | 0 | -3,698 | -2,475 |
| Capital Expenditure | -2 | 0 | N/A | -66 | -40 |
| Free Cash Flow | -4,286 | -1,904 | 0 | -3,764 | -2,515 |